中华人民共和国疫苗管理法（征求意见稿）(92)
<P style="LINE-HEIGHT: 150%; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; mso-char-indent-count: 2.0" class=MsoNormal><FONT face="Times New Roman"><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">《征求意见稿》共十一章，分别为：总则、疫苗研制和上市许可、疫苗生产和批签发、上市后研究和管理、疫苗流通、预防接种、异常反应监测与补偿、保障措施、监督管理、法律责任和附则。重点是结合疫苗研制、生产、流通、预防接种的特点，对疫苗监管的特殊要求作出具体规定：</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 16pt; mso-fareast-font-family: 仿宋_GB2312" lang=EN-US><o:p></SPAN></FONT></P>
<P style="LINE-HEIGHT: 150%; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; mso-char-indent-count: 2.0" class=MsoNormal><FONT face="Times New Roman"><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（一）突出疫苗的战略性、公益性。</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">在立法目的中明确提出维护国家安全</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第一条）</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">。在管理上，强调产业调控，</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; COLOR: black; FONT-SIZE: 16pt; mso-bidi-font-weight: bold; mso-ascii-font-family: 'Times New Roman'; mso-ansi-language: ZH-TW">引导和鼓励</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; COLOR: black; FONT-SIZE: 16pt; mso-bidi-font-weight: bold; mso-ascii-font-family: 'Times New Roman'; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW" lang=ZH-TW>疫苗生产企业规模化、集约化发展</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第五条）</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">。</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; COLOR: black; FONT-SIZE: 16pt; mso-bidi-font-weight: bold; mso-ascii-font-family: 'Times New Roman'; mso-ansi-language: ZH-TW">加强疫苗安全的宣传教育，普及疫苗安全法律法规以及疫苗安全标准、疫苗接种知识</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第十一条）</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 仿宋_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">。注重信息公开和风险交流，实行疫苗安全信息统一公布制度，要求监管部门对疫苗质量安全和预防接种等信息组织风险交流</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt">（第七十五条、第七十六条）</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-FAMILY: 楷体_GB2312; FONT-SIZE: 16pt; mso-ascii-font-family: 'Times New Roman'">。</SPAN><SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 16pt; mso-fareast-font-family: 楷体_GB2312" lang=EN-US><o:p></SPAN></FONT></P>


总共97页  [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] 92 [93] [94] [95] [96] [97] 
上一页  下一页